Michael A. Bolen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael A. Bolen has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Zoran B. Popovic
Heart, Vascular and Thoracic Institute, Cleveland Clinic , 9500 Euclid Avenue, Desk J1-5, Cleveland, OH 44195
9 shared publications Scott D. Flamm
Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute (T.K.M.W., C.A., M.C., D.H.K., C.L.J., P.C.C., M.A.B., S.D.F.‚ A.L.K.), Cleveland Clinic, Cleveland, OH
7 shared publications- Paul Schoenhagen
Heart vascular thoracic institute, Cleveland Clinic, OH
6 shared publications - Prabhakar Rajiah
Department of Radiology, Mayo Clinic, Rochester, Minn
4 shared publications Sandra S. Halliburton
Heart & Vascular Institute, Cleveland Clinic, Cleveland, OH, USA; Cardiovascular Imaging, Imaging Institute, Cleveland Clinic, Desk J1-4, 9500 Euclid Avenue, Cleveland, OH, USA
4 shared publicationsNancy A. Obuchowski
Section of Cardiovascular Imaging, Imaging Institute (T.K.M.W., M.B.S., N.A.O., B.X., P.C., R.A.G., S.D.F., Z.B.P., M.A.B.), Cleveland Clinic, OH
3 shared publications
Latest Publications
- 1 August 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (4)
Clinical Applications of Cardiac Diffusion MRI: A Scoping Review
In a scoping review of 55 studies, cardiac diffusion MRI demonstrated the potential for evaluating myocardial microstructure in hypertrophic cardiomyopathy and ischemic heart disease, although clinical adoption remains limited by heterogeneity and limited validation.
- 1 August 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (4)
Clinical Applications of Cardiac Diffusion MRI: A Scoping Review
In a scoping review of 55 studies, cardiac diffusion MRI demonstrated the potential for evaluating myocardial microstructure in hypertrophic cardiomyopathy and ischemic heart disease, although clinical adoption remains limited by heterogeneity and limited validation.
- 1 August 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 7 (4) , e250234
Enlarging Epicardial Cardiac Hemangioma: Serial Multimodality Imaging and Pathologic Correlation
Cardiac hemangioma is a benign tumor that often can be managed conservatively, but in the case of progressive enlargement or associated symptoms, resection may be considered.
- 1 August 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 7 (4) , e250234
Enlarging Epicardial Cardiac Hemangioma: Serial Multimodality Imaging and Pathologic Correlation
Cardiac hemangioma is a benign tumor that often can be managed conservatively, but in the case of progressive enlargement or associated symptoms, resection may be considered.
- 1 January 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (1) , e230200
Artifacts at Cardiac MRI: Imaging Appearances and Solutions
Cardiac MRI is a vital imaging modality for assessing cardiovascular diseases, and its technical challenges can lead to artifacts, making the recognition and mitigation of these artifacts critical for successful cardiac MRI.
- 1 January 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (1) , e230200
Artifacts at Cardiac MRI: Imaging Appearances and Solutions
Cardiac MRI is a vital imaging modality for assessing cardiovascular diseases, and its technical challenges can lead to artifacts, making the recognition and mitigation of these artifacts critical for successful cardiac MRI.
- Open Access
- 19 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7777
The Treatment of Patients with Early-Stage Non-Small Cell Lung Cancer Who Are Not Candidates or Decline Surgical Resection: The Role of Radiation and Image-Guided Thermal Ablation
The standard of care for early-stage NSCLC has historically been surgical resection. Given the association of lung cancer with smoking, a large number of early-stage patients also have active smoking-related medical comorbidities such as COPD precluding surgery. The current approach for treating such inoperable patients is frequently considered to be stereotactic body radiation therapy (SBRT). SBRT (also known as stereotactic ablative radiation therapy or SABR) is a curative modality that precisely delivers very high dose radiation in few (typically <5) sessions. That said, because of their minimal invasiveness and repeatable nature, image-guided thermal ablation therapies such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation (CA) have also been used to treat early-stage lung tumors. For those patients deemed to have “high operative risk” (i.e., those who cannot tolerate lobectomy, but are candidates for sublobar resection), the appropriateness of potential alternatives [e.g., SBRT; ablation] to surgery is an active area of investigation. In the absence of completed randomized phase III trials, the approach to comparing outcomes between surgery, SBRT, or ablative therapies by their efficacy or equivalence is complex. An overview of the role of SBRT and other non-surgical modalities in the management of early-stage lung cancer is the subject of the present review.
- 19 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7777
Open AccessThe Treatment of Patients with Early-Stage Non-Small Cell Lung Cancer Who Are Not Candidates or Decline Surgical Resection: The Role of Radiation and Image-Guided Thermal Ablation
The standard of care for early-stage NSCLC has historically been surgical resection. Given the association of lung cancer with smoking, a large number of early-stage patients also have active smoking-related medical comorbidities such as COPD precluding surgery. The current approach for treating such inoperable patients is frequently considered to be stereotactic body radiation therapy (SBRT). SBRT (also known as stereotactic ablative radiation therapy or SABR) is a curative modality that precisely delivers very high dose radiation in few (typically <5) sessions. That said, because of their minimal invasiveness and repeatable nature, image-guided thermal ablation therapies such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation (CA) have also been used to treat early-stage lung tumors. For those patients deemed to have “high operative risk” (i.e., those who cannot tolerate lobectomy, but are candidates for sublobar resection), the appropriateness of potential alternatives [e.g., SBRT; ablation] to surgery is an active area of investigation. In the absence of completed randomized phase III trials, the approach to comparing outcomes between surgery, SBRT, or ablative therapies by their efficacy or equivalence is complex. An overview of the role of SBRT and other non-surgical modalities in the management of early-stage lung cancer is the subject of the present review.
- Open Access
- 30 January 2024
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 40 (3) , 665-673
Novel contouring method for optimizing MRI flow quantification in patients with aortic valve disease
Optimizing MRI aortic flow quantification is crucial for accurate assessment of valvular disease severity. In this study, we sought to evaluate the accuracy of a novel method of contouring systolic aortic forward flow in comparison to standard contouring methods at various aortic levels. The study included a cohort of patients with native aortic valve (AoV) disease and a small control group referred to cardiac MRI over a 1-year period. Inclusion criteria included aortic flow quantification at aortic valve and one additional level, and no or trace mitral regurgitation (MR) documented both by the MRI AND an echocardiogram done within a year. In addition to flow quantification with standard contouring (SC), a novel Selective Systolic Contouring (SSC) method was performed at aortic valve level, contouring the area demarcated by the AoV leaflets in systole. The bias in each technique’s estimate of aortic forward flow was calculated as the mean difference between aortic forward flow and left ventricular stroke volume (LV SV). 98 patients (mean age 56, 71% male) were included: 33 with tricuspid and 65 with congenitally abnormal (bicuspid or unicuspid) AoV. All methods tended to underestimate aortic forward flow, but the bias was smallest with the SSC method (p < 0.001). Therefore, SSC yielded the lowest estimates of mitral regurgitant volume (4.8 ml) and regurgitant fraction (3.9%) (p < 0.05). SSC at AoV level better approximates LV SV in our cohort, and may provide more accurate quantitative assessment of both aortic and mitral valve function.
- 30 January 2024
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 40 (3) , 665-673
Open AccessNovel contouring method for optimizing MRI flow quantification in patients with aortic valve disease
Optimizing MRI aortic flow quantification is crucial for accurate assessment of valvular disease severity. In this study, we sought to evaluate the accuracy of a novel method of contouring systolic aortic forward flow in comparison to standard contouring methods at various aortic levels. The study included a cohort of patients with native aortic valve (AoV) disease and a small control group referred to cardiac MRI over a 1-year period. Inclusion criteria included aortic flow quantification at aortic valve and one additional level, and no or trace mitral regurgitation (MR) documented both by the MRI AND an echocardiogram done within a year. In addition to flow quantification with standard contouring (SC), a novel Selective Systolic Contouring (SSC) method was performed at aortic valve level, contouring the area demarcated by the AoV leaflets in systole. The bias in each technique’s estimate of aortic forward flow was calculated as the mean difference between aortic forward flow and left ventricular stroke volume (LV SV). 98 patients (mean age 56, 71% male) were included: 33 with tricuspid and 65 with congenitally abnormal (bicuspid or unicuspid) AoV. All methods tended to underestimate aortic forward flow, but the bias was smallest with the SSC method (p < 0.001). Therefore, SSC yielded the lowest estimates of mitral regurgitant volume (4.8 ml) and regurgitant fraction (3.9%) (p < 0.05). SSC at AoV level better approximates LV SV in our cohort, and may provide more accurate quantitative assessment of both aortic and mitral valve function.
- 1 January 2023
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 43 (1) , e220027
Cardiac Nuclear Medicine: Techniques, Applications, and Imaging Findings
Nuclear medicine plays a valuable role in the evaluation of cardiovascular diseases, allowing noninvasive evaluation of cardiac physiology and function that provides complementary information to an...
- 1 January 2023
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 43 (1) , e220027
Cardiac Nuclear Medicine: Techniques, Applications, and Imaging Findings
Nuclear medicine plays a valuable role in the evaluation of cardiovascular diseases, allowing noninvasive evaluation of cardiac physiology and function that provides complementary information to an...
- Open Access
- 1 November 2022
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 15 (11) , 740-747
Prospective Evaluation of the Correlation Between Gated Cardiac Computed Tomography Detected Vascular Fibrosis and Ease of Transvenous Lead Extraction
Background: Difficulty of lead extraction does not track well with procedural complications, but several small retrospective studies have lead fibrosis on computed tomography as an important indicator of difficult lead extraction. The purpose of the present study was to apply a standardized gated cardiac computed tomography (CT) protocol to assess fibrosis and study it prospectively to examine the need for powered sheaths and risk outcomes. Methods: We performed a prospective, blinded, multicenter, international study at high-volume lead extraction centers and included patients referred for transvenous lead extraction with at least one lead with a dwell time >1 year and ability to receive a cardiac CT. The degree of fibrosis (as measured by amount of lead adherence to vessel wall) was graded on a scale of 1 to 4 by dedicated CT readers in 3 zones (vein entry to superior vena cava, superior vena cava, and right atrium to lead tip). The primary outcome of the study was number of extractions requiring powered sheaths at zone 2 for each fibrosis group. Results: A total of 200 patients were enrolled in the trial with 196 completing full gated CT and lead extraction analysis. The primary endpoint of powered sheath (laser and mechanical) sheath use was significantly higher in patients with higher fibrosis seen on CT (scores 3+4; 67.8%) at the zone 2 compared to patients with lower fibrosis (scores 1+2; 38.6%; P <0.001). There were 5 major complications with 3 vascular lacerations all occurring in zone 2 in the study. Conclusions: Gated, contrasted CT can predict the need for powered sheaths by identification of fibrosis but did not identify an absolute low-risk cohort who would not need powered sheaths. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03772704.
- 1 November 2022
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 15 (11) , 740-747
Open AccessProspective Evaluation of the Correlation Between Gated Cardiac Computed Tomography Detected Vascular Fibrosis and Ease of Transvenous Lead Extraction
Background: Difficulty of lead extraction does not track well with procedural complications, but several small retrospective studies have lead fibrosis on computed tomography as an important indicator of difficult lead extraction. The purpose of the present study was to apply a standardized gated cardiac computed tomography (CT) protocol to assess fibrosis and study it prospectively to examine the need for powered sheaths and risk outcomes. Methods: We performed a prospective, blinded, multicenter, international study at high-volume lead extraction centers and included patients referred for transvenous lead extraction with at least one lead with a dwell time >1 year and ability to receive a cardiac CT. The degree of fibrosis (as measured by amount of lead adherence to vessel wall) was graded on a scale of 1 to 4 by dedicated CT readers in 3 zones (vein entry to superior vena cava, superior vena cava, and right atrium to lead tip). The primary outcome of the study was number of extractions requiring powered sheaths at zone 2 for each fibrosis group. Results: A total of 200 patients were enrolled in the trial with 196 completing full gated CT and lead extraction analysis. The primary endpoint of powered sheath (laser and mechanical) sheath use was significantly higher in patients with higher fibrosis seen on CT (scores 3+4; 67.8%) at the zone 2 compared to patients with lower fibrosis (scores 1+2; 38.6%; P <0.001). There were 5 major complications with 3 vascular lacerations all occurring in zone 2 in the study. Conclusions: Gated, contrasted CT can predict the need for powered sheaths by identification of fibrosis but did not identify an absolute low-risk cohort who would not need powered sheaths. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03772704.
- 1 July 2022
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 15 (7) , e014283
Cardiac Magnetic Resonance Imaging Techniques and Applications for Pericardial Diseases
Cardiac magnetic resonance imaging plays a central role among multimodality imaging modalities in the assessment, diagnosis, and surveillance of pericardial diseases. Clinicians and imagers should have a foundational understanding of the utilities, advantages, and limitations of cardiac magnetic resonance imaging and how they integrate with other diagnostic tools involved in the evaluation and management of pericardial diseases. This review aims to outline the contemporary magnetic resonance imaging sequences used to evaluate the pericardium, followed by exploring the main clinical applications of magnetic resonance imaging for identifying pericardial inflammation, constriction, and effusion.
- 1 July 2022
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 15 (7) , e014283
Cardiac Magnetic Resonance Imaging Techniques and Applications for Pericardial Diseases
Cardiac magnetic resonance imaging plays a central role among multimodality imaging modalities in the assessment, diagnosis, and surveillance of pericardial diseases. Clinicians and imagers should have a foundational understanding of the utilities, advantages, and limitations of cardiac magnetic resonance imaging and how they integrate with other diagnostic tools involved in the evaluation and management of pericardial diseases. This review aims to outline the contemporary magnetic resonance imaging sequences used to evaluate the pericardium, followed by exploring the main clinical applications of magnetic resonance imaging for identifying pericardial inflammation, constriction, and effusion.
- 10 May 2022
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 19 (5) , S37-S52
ACR Appropriateness Criteria® Dyspnea-Suspected Cardiac Origin (Ischemia Already Excluded): 2021 Update
- 10 May 2022
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 19 (5) , S37-S52
ACR Appropriateness Criteria® Dyspnea-Suspected Cardiac Origin (Ischemia Already Excluded): 2021 Update
- 1 February 2021
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 216 (2) , 329
Editorial Comment on “Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated With Cystic Airspaces: A Systematic Review and Meta-Analysis”
This Editorial Comment discusses the following AJR article: Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated with Cystic Airspaces: A Systematic Review and Meta-Analysis.
- 1 February 2021
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 216 (2) , 329
Editorial Comment on “Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated With Cystic Airspaces: A Systematic Review and Meta-Analysis”
This Editorial Comment discusses the following AJR article: Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated with Cystic Airspaces: A Systematic Review and Meta-Analysis.